Allergy Therapeutics plc
Block Listing Interim Review
Date 8 March 2023
Name of applicant:
ALLERGY THERAPEUTICS PLC
Name of scheme:
Allergy Therapeutics plc 2013 Long Term Incentive Plan
Period of return:
From:
1 August 2022
To:
28 February 2023
Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission:
10,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 24 November 2017
Balance of unallotted securities under scheme(s) from previous return:
7,118,772 ordinary shares
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
Nil
Less: Number of securities issued/allotted under scheme(s) during period:
Nil
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
7,118,772 ordinary shares
Name of contact: |
Karley Cheesman |
Telephone number of contact: |
+44 (0) 1903 844 700 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDBLREAXDPEAXDEFA You are subscribed to notifications from Allergy Therapeutics Investor Relations e-mail notifications with the email .
Allergy Therapeutics